Assessing incident cardiovascular and metabolic diseases in epidemiological cohort studies in Germany

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz
Wolfram J HerrmannTobias Pischon

Abstract

Cardiovascular and metabolic diseases are a major cause of mortality and loss of quality of life in Germany. Research into risk factors of these diseases requires large population-based cohort studies. Complete and accurate assessment of the incidence of cardiovascular and metabolic diseases is a key element for valid interpretation of the results from such studies. Our aim was to identify population-based cohort studies with incidence of cardiovascular and metabolic diseases in Germany and to summarize their methods for assessment and classification of disease endpoints, including myocardial infarction, type 2 diabetes, stroke, heart failure, and arterial hypertension. Within the framework of a workshop, representatives of the ascertained population-based cohort studies in Germany with incidence of cardiovascular or metabolic diseases were invited to present and to systematically provide information on their methods of endpoint identification. We identified eight studies from different regions in Germany with a total of 100,571 participants, aged 18-83 years at baseline. Self-reporting by study participants is the major source for further inquiries to assess disease endpoints in these studies. Most studies use additional data ...Continue Reading

References

May 1, 1977·American Journal of Epidemiology·K T CopelandR H Holbrook
Nov 14, 1985·The New England Journal of Medicine·T KircherH Burdo
Jul 21, 2005·Das Gesundheitswesen·R HolleUNKNOWN MONICA/KORA Study Group
Jun 22, 2007·Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·T Schelhase, S Weber
Aug 5, 2008·European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology·Hans-Werner HenseUlrich Keil
Nov 6, 2008·Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·W HoffmannK Fendrich
Mar 1, 2012·Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·I K WolfB M Kurth
Jun 28, 2012·Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·H Völzke
Jun 28, 2012·Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·R ErbelK-H Jöckel
Jun 28, 2012·Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·P S WildS Blankenberg
May 21, 2014·European Journal of Epidemiology·UNKNOWN German National Cohort (GNC) Consortium
Jun 17, 2015·Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·Wolfgang Ahrens, K-H Jöckel
Jan 23, 2016·International Journal of Mental Health and Addiction·Adam RzetelnySteven D Passik
May 14, 2016·Science Translational Medicine·Elias Zerhouni, Margaret Hamburg
Jan 12, 2017·Deutsches Ärzteblatt International·Hannelore NeuhauserMarcus Dörr

❮ Previous
Next ❯

Citations

Mar 12, 2020·Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·Wolfgang AhrensIris Pigeot
Mar 12, 2020·Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·Lina JaeschkeTobias Pischon
Dec 8, 2020·Zeitschrift für Psychosomatische Medizin und Psychotherapie·Karl-Heinz Ladwig

❮ Previous
Next ❯

Related Concepts

Related Feeds

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.